<!doctype html>
<html lang="en">
    <head>
        <meta charset="utf-8"/>
        <meta name="viewport" content="width=device-width,initial-scale=1,user-scalable=no"/>
        <meta name="format-detection" content="telephone=no"/>
        <meta name="apple-mobile-web-app-capable" content="yes"/>
        <meta name="apple-mobile-web-app-status-bar-style" content="black"/>
        <title><!-- Key Message Description --></title>
        <link rel="stylesheet" href="../shared/shared-dificid-v4/js/ext/avModal/themes/default.css"/>
        <link rel="stylesheet" href="../shared/shared-dificid-v4/css/shared-main.css"/>
        <link rel="stylesheet" href="css/specific.css"/>
    </head>
    <body data-pix="true" data-SlideName="Considerations">
    	<section id="wrapper">
            <!-- Landscape Header with Tracking -->
    		<header class="landscapeHeader">
                 <div class="homeIcon" data-slide="0.0_dificid_v4_home.zip">&nbsp;</div>
                <div class="halfMoon" id="halfMoonTOC">&nbsp;</div>      
            </header>
           
    		<section id="contentWrapper">
    			<div id="content"> <!--====== main content Starts ========--> 
                    <!-- Navigation Starts-->
                    <nav data-count="six">&nbsp;</nav>
                    <!-- Navigation Ends --> 
                    <!-- Landscape Start -->
                    <div id="landscape">
                        <!-- Slide Specific Code Start -->
                        <section>
                            <div class="considerationsBack">
                                
                            </div>
                            <div class="headerConsideration darkGreen light fs29">
                                Non-study considerations
                            </div>
                            <div class="headerConsiderationDesc fs14 lh18">
                                Considerations below were not a part of the independent evaluation: Cost-effectiveness of<br/>
                                treatment regimens for <span class="italic">Clostridium difficile</span> infection—an evaluation of the 2018 Infectious<br/>
                                Diseases Society of America guidelines.
                            </div>
                            <div class="recommendationCDI helveticaBold darkGreen fs18">
                                Recommendation of vancomycin for severe CDI
                            </div>
                            <div class="recommendationCDIContentOne fs14 lh18">
                                The primary study that drove the estimate for vancomycin cure in severe CDI was a
                            </div>
                            <div class="recommendationCDIContentTwo fs14 lh18">
                                randomized controlled trial of fidaxomicin to vancomycin for CDI, with severe CDI<br/>
                                sub-group sample sizes of:
                            </div>
                            <ul class="considerationContentListOne helveticaBold fs14 lh25">
                                <li>
                                    Fidaxomicin: 112
                                </li>
                                <li>
                                    Vancomycin: 123
                                </li>
                            </ul>
                            <div class="inAddition fs14 lh18">
                                In addition, 2 of the studies cited by the authors defined severe CDI differently:
                            </div>
                            <ul class="considerationContentListTwo lh18 fs14">
                                <li class="mrBtm7">
                                    <span class="helveticaBold">Louie et al.</span> The presence of &ge;10 unformed bowel movements per day or a white-cell<br/>
                                    <span>count of &ge;15,001 per cubic millimeter)</span>
                                </li>
                                <li>
                                    <span class="helveticaBold">Cornely et al.</span> &gt;15 000 white blood cells per &mu;L, serum creatinine concentration &gt;1&middot;5<br/>
                                    mg/dL, or body temperature &gt;38.5&deg;C
                                </li>
                            </ul>
                            <div class="recommendationFMT helveticaBold darkGreen fs18">
                                Recommendation of FMT for subsequent recurrence
                            </div>
                            <div class="costs fs14 lh18">
                                Costs for FMT were taken from CMS and published studies. FMT preparation costs<br/>
                                ranged from $226.54-$485.
                            </div>
                            <div class="afterStudy fs14 lh18">
                                After the study was published FMT preparation costs increased by 300% to 600%:
                            </div>
                            <ul class="considerationContentListThree lh25 fs14">
                                <li>
                                    FMT Upper or Lower Delivery: $1595 per dose (1 bottle)
                                </li>
                                <li>
                                    FMT Capsule: $1950 per dose (1 bottle = 30 capsules)
                                </li>
                            </ul>
                            <div class="bottomtxt  fs14 lh17">Provided pursuant to FDAMA §114.</div>
                        </section>
                        <!-- Slide Specific Code End -->
                        
                        <!-- SmartBalance Headline Start -->
                        <div class="ssiTxt">
                            Important Safety Information
                        </div>
                        <!-- SmartBalance Headline End -->
                        
                        <!-- SmartBalance Content starts -->
                        <section id="smartBalance">&nbsp;</section>
                        <!-- SmartBalance Content ends -->
                    </div>
                    <!-- Landscape End -->
                   
    			</div> <!--======== main content Ends ===========-->
    		</section><!--//contentWrapper-->

    		<footer data-count="six">&nbsp;</footer>
    	</section><!--//wrapper-->

    	<!-- ================= Global popups Start=====================-->
        <section id="globalComponent">&nbsp;</section>
    	<!-- ================= Global popups End=====================-->
       
        <script src="../shared/shared-dificid-v4/js/jquery-2.2.3.min.js" charset="utf-8"></script>
        <script src="../shared/shared-dificid-v4/shared-main.js" charset="utf-8"></script>
    </body>
</html>